Objectives: To determine whether end-tidal Co 2 -guided chest compression delivery improves survival over standard cardiopulmonary resuscitation after prolonged asphyxial arrest. Design: Preclinical randomized controlled study.
S urvival to discharge from out-of-hospital cardiac arrest in infants and children remains low (< 10%) despite guidelines that emphasize chest compression delivery (1) (2) (3) (4) (5) . After a prolonged cardiac arrest, resuscitation efforts must be maximally effective to achieve return of spontaneous circulation (ROSC) and minimize neurologic injury (1, 2, 6) . Resuscitation methods that incorporate physiologic feedback have the potential to individualize and optimize chest compression delivery, increase the effectiveness of resuscitative efforts, and improve outcome. A previously described resuscitation method that incorporates physiologic feedback is hemodynamicdirected cardiopulmonary resuscitation (CPR), which uses arterial pressure monitoring. Hemodynamic-directed CPR has been used to guide chest compression delivery (increased rate and force) and epinephrine administration frequency in adults (7) and to improve outcome in animal models (8) (9) (10) .
A novel physiologic feedback technique for guiding resuscitation efforts uses end-tidal Co 2 (ETCo 2 ) as an indicator of chest compression efficacy (11) . The basis for this method is that the ETCo 2 level during CPR represents the movement of blood containing Co 2 to the lungs and thereby becomes a surrogate for resuscitation-generated systemic blood flow (cardiac output). This relationship of the ETCo 2 level with systemic blood flow is strong because during CPR, the ETCo 2 level becomes less dependent on Co 2 production and minute ventilation and more dependent on cardiac output (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . An advantage to using ETCo 2 level as physiologic feedback during CPR is that it can be measured both easily and continuously. ETCo 2 physiologic feedback also has the potential to be used with the currently recommended quality feedback about chest compression rate, depth, and release and with the promising physiologic feedback method of hemodynamic-directed CPR.
The 2015 American Heart Association (AHA) resuscitation guidelines suggested the use of ETCo 2 during adult CPR as a prognostication tool either immediately after intubation or after 20 minutes of resuscitation but did not provide instruction for using ETCo 2 to direct resuscitation efforts (25) . The pediatric 2015 AHA guidelines reported a lack of evidence about the use of ETCo 2 to direct chest compression delivery and were unable to make a recommendation (26) . The 2013 AHA consensus regarding CPR quality and resuscitation outcome improvement suggested the development of "a more reliable, inexpensive, noninvasive physiologic monitor that will increase our ability to optimize CPR for individual victims of cardiac arrest" and recommended that future research "determine optimal titration of hemodynamic and ETCo 2 monitoring during human CPR" (27) .
In our previous study that used a brief (90 s) fibrillatory cardiac arrest, the use of ETCo 2 feedback to guide chest compression delivery was equivalent to using quality feedback about compression rate and depth (11) . In the current study, we used a more prolonged (20 min) asphyxial cardiac arrest to determine if ETCo 2 -guided chest compression delivery can improve survival compared with standard CPR guided by rate and depth feedback. We also investigated concerns that the hypercarbia from asphyxia or the administration of epinephrine during advanced life support (ALS) might confound the use of ETCo 2 -guided compression delivery. We hypothesized that if extreme hypercarbia and epinephrine administration do not interfere, then the use of ETCo 2 -guided chest compression delivery after a prolonged cardiac arrest would optimize resuscitative efforts and improve survival over standard CPR.
MATERIALS AND METHODS
All studies were carried out with approval from the Animal Care and Use Committee of Johns Hopkins University in accordance with institutional guidelines. Twenty-eight male domestic swine (7-14 d old, 3-4 kg) received anesthesia induction and maintenance with 2% isoflurane, 70% nitrous oxide, and 30% oxygen. A 4.0 cuffed tracheal tube was secured via tracheostomy. A femoral artery catheter was advanced to the mid-aorta for hemodynamic and blood gas determinations. A pacing wire placed through one femoral vein was advanced into the right ventricle as indicated by ventricular irritation on electrocardiogram. A catheter advanced through the other femoral vein to a mid-thoracic position was used to measure central venous pressure (CVP) and to administer fluid and epinephrine. A sagittal sinus catheter was placed through a burr hole at the bregma to measure intracranial pressure (ICP) and venous blood gases. Finally, the anteroposterior chest diameter was measured before arrest (and after CPR) to determine compression-induced deformity. After the surgery, isoflurane was decreased and fentanyl (10 µg/kg) and vecuronium (0.3 mg/kg) administered. A heating pad was adjusted to maintain rectal temperature at 38-39°C. Pressure-controlled ventilation was adjusted to maintain a Paco 2 of 35-45 torr at a rate of 20 breaths per minute, and Fio 2 was decreased from 30% to 21%. Vital signs, including ETCo 2 , mean arterial blood pressure (MAP), mean CVP, arterial relaxation pressure (aka diastolic blood pressure [DBP]), mean ICP, heart rate, and rectal temperature were recorded before protocol initiation (baseline) and at 30-second intervals during CPR. Hemodynamic values measured during the interval of ALS after ROSC were removed from the values on the graphs displayed as ALS.
Experimental Protocol
A timeline for the experimental protocol is provided in Figure 1 . We produced a 20-minute asphyxial ventricular fibrillation arrest by clamping the tracheostomy tube for 14 minutes and then inducing 6 minutes of fibrillation by applying 50 mA of ac via the pacing wire. This procedure was similar to the model used to study hemodynamic-directed CPR (8) . We included the period of fibrillation to prevent ROSC during the 10-minute basic life support (BLS) interval. This guaranteed 10-minute interval without ROSC allowed hemodynamic comparison between study groups during BLS. We chose to induce fibrillation at 14 minutes because this duration allowed the asphyxia to proceed to pulselessness (which usually requires 8-12 min) and was not so long that the hypoxemia produced a low amplitude fibrillation that was difficult to detect. After the 20 minutes of arrest, BLS was begun. Ventilation was resumed with an Fio 2 of 1.0, the prearrest rate of 20 breaths/min, and the prearrest inspiratory pressures. The heating pad was adjusted to maintain rectal temperature at 38-39°C during CPR. In both groups, resuscitators performed chest compressions with a twothumb, encircling technique at a compression rate that varied by study group (see below). The resuscitators providing chest compression delivery switched every 2 minutes.
Standard Group. In this group, a marker was placed across the animal at 2/3 the anteroposterior diameter for chest compression depth (see Fig.1 in Hamrick et al [11] ). The targets for chest compression delivery throughout BLS and ALS were a rate of 100/min, a depth of 1/3 the anteroposterior diameter, and full release between compressions. Real-time video and verbal feedback about the rate, depth, and release were provided. The resuscitators were blinded to the ETCo 2 value.
ETCo 2 Group. In this group, resuscitators adjusted the chest compression rate, force, depth, and thumb positions throughout BLS and ALS to maximize the level of ETCo 2 produced. ETCo 2 level was the only feedback available.
Both Groups. After the 10-minute interval of BLS, ALS was begun. Resuscitators administered 30 joules of biphasic defibrillation during compressor changes at 0, 2, 4, 6, and 8 minutes of ALS. Additionally, 300 µg of epinephrine was administered into the mid-thoracic venous catheter at 0, 4, and 8 minutes of ALS. ALS was terminated when ROSC occurred or after 10 minutes (20 min of CPR total). Survival was defined as continued ROSC (sustained arterial pulsatility) for 20 minutes without further intervention. Nonsurvival was no ROSC after 10 minutes of ALS (20 min of CPR) or ROSC that was not sustained for 20 minutes. No additional compressions, medications, or defibrillations were provided after ROSC occurred. Arterial and venous blood gases were examined at baseline, 10 minutes of asphyxia, 8 minutes of BLS, and 20 minutes of ALS for nonsurvivors or 20 minutes of ROSC for survivors. After 20 minutes of ROSC, survivors were euthanized per Animal Care and Use Committee guidelines. We performed autopsies on all animals to determine resuscitation-related injuries (superficial liver injury, hemoperitoneum, hemothorax, hemopericardium, atelectasis, or superficial cardiac injury).
Statistical Analysis
Descriptive data were used to characterize baseline cardiorespiratory variables. All values are expressed as mean ± sd. Systemic perfusion pressure (SPP) was calculated as MAPmean CVP. Cerebral perfusion pressure (CPP) was calculated as MAP-mean ICP. Differences between groups in resuscitation and injury statistics were compared with an unpaired, two-tailed t test for continuous variables and chi-square or Fisher exact test for categorical variables, as appropriate. p values of less than 0.05 were considered statistically significant. Repeated-measures analysis of variance (ANOVA) was used to investigate the effect of time and group. All data were analyzed in Stata (Version 14; Statacorp LP, College Station, TX).
RESULTS
Baseline blood gas and hemodynamic results were similar between study groups ( Table 1) . Paco 2 at 10 minutes of asphyxia averaged 122 and 124 torr in the ETCo 2 and standard groups, respectively. ETCo 2 at the start of chest compressions exceeded the limit of detection (> 99 torr) in both groups. At 30 seconds of chest compressions, ETCo 2 averaged 64 and 65 torr, and at 1 minute, it was 32 ± 10 and 25 ± 8 torr (p = 0.046) in the ETCo 2 and standard groups, respectively ( Fig. 2A) . ETCo 2 throughout CPR was greater than 30 torr in the ETCo 2 group but fell to 11.5 torr in the standard group. The Paco 2 at 8 minutes of BLS was 54 ± 20 in the ETCo 2 group and 42 ± 30 torr (p = 0.23) in the standard group. The ETCo 2 was higher in the ETCo 2 group than in the standard group during both BLS and ALS ( Table 2) . ETCo 2 did not change with epinephrine administration at 10, 14, or 18 minutes of CPR in either study group nor when analyzed for survival. ETCo 2 level during BLS was higher in survivors ( Table 3) .
The ROSC rate was greater in the ETCo 2 group (50% vs 14%, p = 0.04) ( Table 4) . Two of the seven nonsurvivors in the ETCo 2 group had ROSC less than the required 20 minutes (8 and 16 min), none of the 12 nonsurvivors in the standard group had ROSC of any duration. There were no differences between groups in defibrillation attempts, time to defibrillation, or epinephrine doses. Figure 3A shows the ETCo 2 level during CPR by survival and illustrates that survivors had consistently higher ETCo 2 levels after 1 minute of CPR. Figure 3A1 shows the ETCo 2 level during CPR by group and survival. In the ETCo 2 group, both survivors and nonsurvivors maintained ETCo 2 during CPR in the high 20s to 30 torr, whereas the ETCo 2 in the standard group showed the expected relationship with survival (high 20s in survivors, low 10s in nonsurvivors).
The chest compression rate over the 20 minutes of CPR was 102 ± 2/min (range, 84-114) in the standard group and 143 ± 10/min (range, 72-182) in the ETCo 2 group (p < 0.0001) ( Table 2 and Fig. 2B ). Compression rate did not differ by survival (Table 3 ) (p = 0.14).
The DBP (an indicator of coronary perfusion during CPR) did not differ between study groups during BLS, but it was higher in the ETCo 2 group during ALS (Table 2 and Fig. 2C ). The ETCo 2 group exhibited a greater increase in DBP than did the standard group 1 minute after the first epinephrine administration (DBP: 20 ± 16 vs 7 ± 7 mm Hg; p = 0.01). Survivors exhibited higher DBP early in BLS (0-8 min; 18.5 ± 7 vs 11.6 ± 7 mm Hg; p = 0.02) but not during late BLS (8-10 min; 10.7 vs 10.7) (Fig. 3B) . During ALS, DBP was higher in survivors than in nonsurvivors (Fig. 3B) . Figure 3B1 shows that the DBP during BLS was similar for survival between study groups, unlike the ETCo 2 level in Figure 3A1 . The first epinephrine administration produced a greater increase in DBP in survivors than in nonsurvivors (25 ± 17 vs 8 ± 7 mm Hg; p = 0.001). ANOVA of DBP by group and survival showed a significant difference during ALS (p = 0.01), with DBP in ETCo 2 -guided survivors higher than that in standard group nonsurvivors (p = 0.001) and ETCo 2 group nonsurvivors (p = 0.04) (Fig. 3B1) .
MAP, CVP, and ICP (but not SPP or CPP) were higher in the ETCo 2 group than in the standard group during BLS (Table 2 and Fig. 2, D-H) , but all five variables were higher in the ETCo 2 group during ALS. After the first epinephrine administration, we observed greater increases in MAP (24 ± 18 vs 9 ± 11 mm Hg; p =0.02), SPP (23 ± 18 vs 9 ± 12 mm Hg; p = 0.01), and CPP (21 ± 16 vs 9 ± 11 mm Hg; p = 0.03), but not CVP or ICP, in the ETCo 2 group. MAP, CPP, ICP, and SPP were higher in survivors than in nonsurvivors during ALS (Table 3 and Fig. 3, C and D) . After the first epinephrine administration, MAP increased more in survivors than in nonsurvivors (33 ± 18 vs 9 ± 8 mm Hg; p = 0.0001) as did SPP (30 ± 21 vs 9 ± 9 mm Hg; p = 0.0005), ICP (4 ± 7 vs 0.3 ± 3 mm Hg; p = 0.03), and CPP (29 ± 18 vs 9 ± 8 mm Hg; p = 0.0003). ANOVA of SPP by group and survival demonstrated a significant difference during ALS (p = 0.02), with SPP in the ETCo 2 group survivors and nonsurvivors being greater than that of the standard group nonsurvivors (p = 0.006 and p = 0.031, respectively) (Fig. 3C1) .
Autopsy results revealed that the chest deformity (change in prearrest to postresuscitation anteroposterior chest diameter) was less in the ETCo 2 group than in the standard group (1.1 ± 0.7 vs 1.8 ± 1.0 cm; p = 0.05). This difference may be due to restoration of chest shape by ventilation during the period of ROSC, which occurred more often in the ETCo 2 group. Epicardial hemorrhages, which were superficial and along the distribution of the right coronary artery, were greater in the ETCo 2 group (77% vs 33%). These superficial hemorrhages were more common in survivors than in nonsurvivors in both groups (78% vs 37%). If related to resuscitative efforts, their presence did not appear to interfere with the rate of ROSC. We also noted a nonsignificant increase in hemothorax in the ETCo 2 -guided group. These hemothoraces appeared to be caused by the fibrillation wire perforating the vasculature during BLS and were corrected by withdrawing the wire before CPR in subsequent experiments. Other injuries did not differ between study groups (Table 4) . 
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DISCUSSION
This proof-of-concept study showed that ETCo 2 -guided chest compression can improve survival compared with standard CPR for cardiac arrest. By providing real-time, physiologic feedback, ETCo 2 monitoring enabled rescuers to adjust chest compression delivery to optimize the patient's response. In this study, resuscitators adjusted chest compression factors such as hand position, rate, depth, force, and release in response to ETCo 2 level. The sustained improvement in the ETCo 2 level is believed to correspond to improved pulmonary blood flow and systemic cardiac output. The higher ETCo 2 level and ROSC rate in the ETCo 2 -guided group were due primarily to increases in chest compression rate and force in response to the ongoing feedback. The observers thought that chest compression release was good and that neither group exhibited excessive leaning. In one of the ETCo 2 -guided experiments, the ETCo 2 level improved noticeably when the compressor's thumbs were moved to the left of midline, but no change in ETCo 2 was noticed with hand position changes in the other 13 experiments of that group. Because a pediatric accelerometer did not work well on the small chest of the animals, objective data for depth and force are not available. The increases in MAP, mean CVP, and mean ICP seen in the ETCo 2 -guided group probably represent an increase in force by the resuscitators. The increased force did not cause significant chest compression deformity or injuries detected by autopsy. The chest compression rate was considerably increased by the resuscitators in the ETCo 2 -guided group to maximize ETCo 2 levels (126/min at 30 s to 157/min at 20 min) (Fig. 2B) . The benefit of the fast compression rate may be specific for our model and relate to the very compliant chest wall and a cardiac pump type mechanism of blood flow (28) . Additional research is needed to determine if the use of compression rates above the guideline recommendations (100-120/min) are effective and safe before this method is considered for clinical use. In our previous study, ETCo 2 -guided CPR was comparable with standard CPR after a short-duration arrest interval (11) . In that study, the group guided by ETCo 2 alone saw a 70% rate of ROSC, whereas the standard CPR group, which received verbal and visual feedback about CPR quality, saw a 65% rate of ROSC. In the current study, we tested whether ETCo 2 -guided chest compression delivery would improve the rate of ROSC when survival from standard CPR was likely to be very low. Therefore, we used a prolonged, 20-minute asphyxia-ventricular fibrillation arrest model that produces an ROSC rate of only 14% with standard CPR. The 50% rate of ROSC with ETCo 2 -guided chest compression indicates that this method has the potential to improve resuscitative efforts after prolonged arrest or during prolonged resuscitation.
An interesting finding is that survivors and nonsurvivors in the ETCo 2 group had similar ETCo 2 levels (approximately 30 mm Hg) throughout CPR. Low levels of ETCo 2 during CPR have been associated with low-quality CPR, a decreased rate of ROSC, and futility, whereas high levels of ETCo 2 have been associated with survival (18, 25, 29) . Our results indicate that attempting to raise ETCo 2 levels during CPR can result in increased ETCo 2 levels that do not indicate likelihood of ROSC. Figure 3B1 shows that the relationship between the relaxation arterial pressure (a surrogate for myocardial perfusion [10, [30] [31] [32] ) and survival is present in both study groups during BLS. In contrast, the ETCo 2 , SPP, and CPP levels during BLS in the nonsurvivors of the ETCo 2 -guided group overlap the survivors of both groups (Fig. 3, A1, C1, and D1) . The ETCo 2 levels produced by ETCo 2 -guided chest compression delivery appear to correspond better to systemic perfusion than myocardial perfusion. Despite this apparent disconnect between ETCo 2 and DBP, the ETCo 2 -guided group was more likely to experience ROSC. The increased response in MAP and DBP in the ETCo 2 group to early epinephrine administration suggests that improved systemic perfusion better maintains vascular responsiveness during prolonged CPR. A better understanding of the relationship between DBP and ETCo 2 during prolonged CPR is needed to determine how to maximize both when ROSC is difficult to achieve.
One concern of using ETCo 2 -guided chest compression for pediatric arrest has been that significant hypercarbia caused by prolonged asphyxia might cofound implementation of ETCo 2 guidance. The ETCo 2 in the standard and ETCo 2 groups fell to 25 and 32 mmHg, respectively, at 1 minute of CPR, a range that was useful and persisted during the remainder of resuscitation. Others have also reported a similar rapid decrease in ETCo 2 after asphyxial arrest (33, 34) . Another potential confounder of ETCo 2 -guided CPR is that epinephrine administration might affect pulmonary blood flow and ETCo 2 levels. Others have reported that ETCo 2 levels could be temporarily increased or decreased after epinephrine administration (35) (36) (37) (38) (39) (40) (41) (42) . However, we did not observe fluctuations in ETCo 2 in either study group after epinephrine administration at 10, 14, or 18 minutes of CPR ( Fig. 2A) . The fact that ETCo 2 levels did not decrease as the effect of epinephrine on DBP and SPP (Fig. 2, C and F) wore off at 12 and 16 minutes of CPR may indicate that ETCo 2 cannot be used to guide early epinephrine administration and that invasive monitoring would be most useful for this role. We will need additional studies to determine if the lack of ETCo 2 responsiveness to epinephrine administration is due to the long arrest interval used in this model. In our previous study that used a short arrest interval, most animals achieved ROSC with the first epinephrine dose, making it difficult to know if the increased ETCo 2 level was from epinephrine, impending ROSC, or both (11) .
CPR guided by physiologic feedback has the potential to improve cardiac and neurologic outcomes when resuscitation efforts become prolonged. Extracorporeal CPR technology is improving, but rates of neurologic injury and failure to wean from support after recovery remain high. Hemodynamic-directed CPR has shown great promise for improving survival and neurologic outcome in preclinical models when an arterial catheter is present to guide epinephrine administration (8) (9) (10) 32) . Near-infrared spectroscopy measurements and amplitude analysis of ventricular fibrillation are other physiologic responses that have the potential to guide resuscitation efforts. Resuscitation guidelines offer evidence-based recommendations for a common initial resuscitation approach and for CPR quality. The use of physiologic feedback offers the potential to maximize those recommendations, individualize efforts, and, when needed, modify resuscitative efforts beyond current guidelines. Several limitations of this study deserve attention. First, rate of ROSC is a limited outcome measure for resuscitation studies. Longer term outcomes and neurologic status are much more useful and will need to be addressed in future studies. With the current prolonged arrest interval, long-term survival will likely require intensive care, and neurologic outcomes may be very poor. Second, we did not have an accelerometer to measure compression depth, force, or release. Chest compression rate was the only objective measure we had of alterations to CPR delivery. It is very likely that force, and possibly depth or release, was different between groups and contributed to our findings. When a neonatal accelerometer becomes commercially available, it would be very useful to add it to our studies. Third, it is unclear whether an asphyxial arrest model in healthy animals is applicable to neonatal, infant, or pediatric arrests. This model might correlate with apnea that leads to arrest in cases of sudden infant death syndrome, choking, suffocation, or drowning. However, the study does not address the usefulness of an ETCo 2 -guided resuscitation method when lung disease leads to respiratory and then cardiac arrest. Therefore, we cannot generalize its applicability to all pediatric cardiopulmonary arrests. Fourth, baseline ventilation parameters (a breath rate of 20 per min) and mechanical ventilation were used during CPR which may limit the clinical applicability of this study. Current recommendations are for reduced breath rates of 10-12 per minute to prevent overventilation during CPR. Mechanical ventilation was continued, rather than switching to manual ventilation, to minimize the number of variables under investigator control in this necessarily unblinded study. Pressure-controlled ventilation is commonly used in children, and its use during experimental CPR can result in reduced tidal volumes and require an increased breath rate. Table 4 shows that the blood gas mean values at 8 minutes of BLS are appropriate (Paco 2 54 and 42 mm Hg and Pao 2 132 and 120 mm Hg) and that using mechanical ventilation and a breath rate of 20 per minute did not produce overventilation. Fifth, the lack of blinding of resuscitators may provide bias in the study. The standard group was observed for performance of the recommended chest compression rate, depth, release, and hand position (see diagrams and description in Hamrick et al [11] ) and was blinded to ETCo 2 level, whereas the experimental group was instructed to improve ETCo 2 levels by adjusting these variables. Thus, improving resuscitator performance in the ETCo 2 group was part of the study design.
Nevertheless, study outcomes were objectively measured (rate of ROSC, hemodynamic variables, and presence of injuries).
CONCLUSIONS
ETCo 2 -guided chest compression delivery has the potential to improve neonatal/infant outcomes from prolonged cardiac arrest over standard CPR. Concerns that interference from hypercarbia or epinephrine administration might interfere with the use of ETCo 2 guidance were unsupported. Additional study is needed to determine the benefit on long-term outcomes of ETCo 2 -guided chest compression delivery and how it can be used to individualize and optimize resuscitation by manipulating parameters within and beyond published guidelines.
